EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Salvianolic acid B in fibrosis treatment: a comprehensive review

Qingzhi Liang, Xiaoqin Liu, Xi Peng, Ting Luo, Yi Su, Xin Xu, Hongyan Xie, Hong Gao, Zhengtao Chen, Chunguang Xie

Frontiers in Pharmacology · 30.07.2024 · 15

DOI: 10.3389/fphar.2024.1442181 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 30.07.2024. Verfasst von Qingzhi Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis is a public health issue of great concern characterized by the excessive deposition of extracellular matrix, leading to the destruction of parenchymal tissue and organ dysfunction that places a heavy burden on the global healthcare system due to its high incidence, disability, and mortality. Salvianolic acid B ( SalB ) has positively affected various human diseases, including fibrosis. In this review, we concentrate on the anti-fibrotic effects of SalB from a molecular perspective while providing information on the safety, adverse effects, and drug interactions of SalB. Additionally, we discuss the innovative SalB formulations, which give some references for further investigation and therapeutic use of SalB ’s anti-fibrotic qualities. Even with the encouraging preclinical data, additional research is required before relevant clinical trials can be conducted. Therefore, we conclude with recommendations for future studies. It is hoped that this review will provide comprehensive new perspectives on future research and product development related to SalB treatment of fibrosis and promote the efficient development of this field.

Schlagwörter

Stichwörter der Autor:innen

Salvianolic acid Bfibrosisnatural productpharmacological mechanismtreatment

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Chengdu, Sichuan, China.
  • Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.

Zitieren

APA

Liang, Q., Liu, X., Peng, X., Luo, T., Su, Y., Xu, X., Xie, H., Gao, H., Chen, Z., & Xie, C. (2024). Salvianolic acid B in fibrosis treatment: a comprehensive review. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1442181

Vancouver

Liang Q, Liu X, Peng X, Luo T, Su Y, Xu X, et al. Salvianolic acid B in fibrosis treatment: a comprehensive review. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1442181

BibTeX
@article{Liang2024,
  author = {Liang, Qingzhi and Liu, Xiaoqin and Peng, Xi and Luo, Ting and Su, Yi and Xu, Xin and Xie, Hongyan and Gao, Hong and Chen, Zhengtao and Xie, Chunguang},
  title = {Salvianolic acid B in fibrosis treatment: a comprehensive review},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1442181}
}
Kostenlos starten →